Óskar Ragnarsson

Improved Cortisol Exposure-Time Profile and Outcome in Patients with Adrenal Insufficiency: A Prospective Randomized Trial of a Novel Hydrocortisone Dual-Release Formulation

Gudmundur Johannsson, A. G. Nilsson, Ragnhildur Bergthorsdottir et al. · The Journal of Clinical Endocrinology & Metabolism · 2011 · 322 citations · Full text

Treatment of aggressive pituitary tumours and carcinomas: results of a European Society of Endocrinology (ESE) survey 2016

Ann McCormack, Olaf M. Dekkers, Stephan Petersenn et al. · European Journal of Endocrinology · 2018 · 269 citations · Full text

The incidence rate of pituitary adenomas in western Sweden for the period 2001–2011

Axel Tjörnstrand, Kerstin Gunnarsson, M Evert et al. · European Journal of Endocrinology · 2014 · 261 citations

Long-Term Outcome and MGMT as a Predictive Marker in 24 Patients With Atypical Pituitary Adenomas and Pituitary Carcinomas Given Treatment With Temozolomide

Daniel Bengtsson, Henrik Daa Schrøder, Marianne Andersen et al. · The Journal of Clinical Endocrinology & Metabolism · 2015 · 183 citations · Full text

Prolonged diagnostic delay in acromegaly is associated with increased morbidity and mortality

Daniela Espósito, Óskar Ragnarsson, Gudmundur Johannsson et al. · European Journal of Endocrinology · 2020 · 126 citations